Genomed SA banner
G

Genomed SA
WSE:GEN

Watchlist Manager
Genomed SA
WSE:GEN
Watchlist
Price: 28.2 PLN -6.62% Market Closed
Market Cap: zł37.2m

Wall Street
Price Targets

GEN Price Targets Summary
Genomed SA

There are no price targets for GEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genomed SA Competitors:
Price Targets
CIGI
Colliers International Group Inc
13% Upside
FSFG
First Savings Financial Group Inc
-1% Downside
ZEAL
Zealand Pharma A/S
76% Upside
BRI
Britania PCL
7% Upside

Revenue
Forecast

6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Revenue forecast
is not available for
Genomed SA

Operating Income
Forecast

18% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
18% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Genomed SA

Net Income
Forecast

19% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
19% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Net Income forecast
is not available for
Genomed SA
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GEN's stock price target?
Not Available

GEN doesn't have any price targets made by Wall Street professionals.

Back to Top